Lexicon Pharmaceuticals (LXRX) Operating Margin Growth (1y) (2011 - 2026)
Lexicon Pharmaceuticals (LXRX) Operating Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1,049.00 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1,238.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -10,520.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -1,651.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2,002.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 29,091.00 |
| 10 | Lexicon Pharmaceuticals | 1.04 Bn | 846.13 Mn | 653,000.00 | -384,820.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -384,820.00 |
| Mar 31, 2026 | 203,007.00 |
| Dec 31, 2025 | -14,579.00 |
| Sep 30, 2025 | 355,367.00 |
| Jun 30, 2025 | 337,384.00 |
| Mar 31, 2025 | 211,279.00 |
| Dec 31, 2024 | 597,815.00 |
| Sep 30, 2024 | 2.70 Mn |
| Jun 30, 2024 | 1.18 Mn |
| Jun 30, 2023 | 5.34 Mn |
| Dec 31, 2020 | -320,669.00 |
| Jun 30, 2020 | -25.62 Mn |
| Mar 31, 2020 | -6,434.00 |
| Dec 31, 2019 | -46,860.00 |
| Sep 30, 2019 | 40,771.00 |
| Jun 30, 2019 | -193,700.00 |
| Mar 31, 2019 | -56,761.00 |
| Dec 31, 2018 | 1,298.00 |
| Sep 30, 2018 | -22,576.00 |
| Jun 30, 2018 | 5,769.00 |